医学
糖尿病性黄斑水肿
眼科
激肽释放酶
黄斑水肿
糖尿病性视网膜病变
糖尿病
视力
内分泌学
生物化学
酶
化学
作者
Jennifer K. Sun,Raj K. Maturi,David S. Boyer,John A. Wells,Victor H. Gonzalez,Robert Tansley,Helen Hernandez,Andreas Maetzel,Edward P. Feener,Lloyd Paul Aiello
标识
DOI:10.1016/j.oret.2019.07.006
摘要
Abstract Safety of the intravitreal plasma kallikrein inhibitor (KVD001) was tested in patients with diabetic macular edema. KVD001 was well tolerated. Systemic absorption was low. Improvement of retinal edema and vision occurred in most study eyes.
科研通智能强力驱动
Strongly Powered by AbleSci AI